Adlai Nortye (ANL) Cash & Equivalents Growth (1y) (2023 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - -68.22%
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - 988.88%
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 214.58%
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn - 15.64%
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - 4.77%
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 17.50%
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn -4.13%
8 Evaxion A 65.44 Bn 65.42 Bn - 3.35%
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 67.78%
10 Adlai Nortye 23,840.00 -8.03 Mn - -86.77%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -86.77%
Jun 30, 2025 -37.84%
Dec 31, 2024 -33.43%
Dec 31, 2023 113.98%